Jon Scott Jacobsen
Corporate Officer/Principal bei ACLARIS THERAPEUTICS, INC.
Profil
Jon Scott Jacobsen is currently working as Chemistry Director at Aclaris Life Sciences, Inc. and as Senior Vice President-Chemistry at Aclaris Therapeutics, Inc. He previously worked as Director-Chemistry Department & Senior Scientist at Pfizer Inc. He completed his undergraduate degree from Harvey Mudd College and his doctorate degree from the University of California, Irvine.
Aktive Positionen von Jon Scott Jacobsen
| Unternehmen | Position | Beginn |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Aclaris Life Sciences, Inc.
 Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jon Scott Jacobsen
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
Ausbildung von Jon Scott Jacobsen
| Harvey Mudd College | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Aclaris Life Sciences, Inc.
Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Health Services |
